The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBatm Advanced Regulatory News (BVC)

Share Price Information for Batm Advanced (BVC)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 18.675
Bid: 18.35
Ask: 19.00
Change: -0.075 (-0.40%)
Spread: 0.65 (3.542%)
Open: 18.75
High: 0.00
Low: 0.00
Prev. Close: 18.75
BVC Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading and Business Update

7 Jan 2014 07:00

RNS Number : 0255X
BATM Advanced Communications Ld
07 January 2014
 



7 January 2014

 

BATM Advanced Communications Limited

("BATM" or "the Group")

 

Trading and Business Update

 

BATM Advanced Communications Limited (LSE: BVC; TASE: BATM), a leading provider of real-time technologies for the networked telecoms and medical laboratory equipment markets, provides the following trading and business update for the 12 months ended 31 December 2013 ahead of its full year results announcement on 25 February 2014.

 

The Group anticipates that revenue for full year 2013 will be in line with expectations at approximately $114m. This reflects a better-than-expected performance in the Medical division and a Telecom division that is stabilizing and at the beginning of its recovery process. Specifically, in the fourth quarter, the Medical division's revenue increased by 20% over the comparative period in 2012. This was due to growth in all three businesses of the division, including the commencement of the contribution to revenue from the medical sterilization unit being marketed by a leading vendor in the US. The diagnostics business performed well, including but not limited to the first sales of its HIV kits, and increased its contribution to revenue in the fourth quarter compared with the equivalent period in 2012.

 

The Telecom division received less-than-expected revenue from clients in the US and Latin America in the fourth quarter, and suffered from a 10% appreciation of the Israeli shekel against the US dollar during 2013 compared with 2012. Whilst the decrease in revenue in the Telecom division was offset by the performance of the Medical division, the latter has lower profit margins than the Telecom division and consequently, as a result of the higher revenue contribution from the Medical division, the Group expects EBITDA (before share-based payments) for 2013 to be below market expectations at approximately $2m-$2.5m.

 

For 2014, the Medical division is expected to continue to expand globally with an increased focus on both diagnostics and medical waste solutions. The Group is expanding production capacity to cope with the increased orders in the sterilization and the diagnostics businesses. As a result, the Group expects to maintain the division's momentum of 2013 into 2014, with higher sales and improving gross margins.

 

Whilst the Telecom division continues to be vulnerable to macro-economic conditions, including that network operators are deliberating over upgrading their systems and the appreciation of the Israeli shekel, the Group expects that trading in this division will firmly stabilise after the first quarter of 2014 and progressively improve thereafter. In the final quarter, Mr Ariel Efrati, who had joined the Group in September 2013 as Chief Operating Officer of BATM, took over as Managing Director of the Telecom division and has commenced driving the business forward in line with the division's new strategy, introduced in Q3 2013, of focusing on Tier 1 and larger customers as well as providing existing customers with state-of-the-art networking equipment.

 

BATM will provide further details on trading and its outlook for 2014 in its full year results announcement.

 

 

 

Enquiries

 

BATM Advanced Communications

Dr Zvi Marom, Chief Executive Officer

+972 9866 2525

Ofer Bar-Ner, Chief Financial Officer 

 

finnCap

Stuart Andrews, Henrik Persson

+44 20 7220 0500

Shore Capital

Pascal Keane

+44 20 7408 4090

Luther Pendragon

Harry Chathli, Claire Norbury

+44 20 7618 9100

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTBQLLBZFFBBBX
Date   Source Headline
2nd May 20247:00 amRNSBATM selected for TB diagnostics programme
18th Apr 20247:00 amRNSBATM to deliver Edgility to new Tier 1 customer
8th Apr 20247:00 amRNSBATM awarded new Edgility contract from Cemex
3rd Apr 20247:00 amRNSAnnual Financial Report
26th Mar 20247:00 amRNSBATM receives $2.3m cyber security orders
12th Mar 20247:00 amRNSFull Year Results
29th Feb 20247:00 amRNSNotice of Results
2nd Jan 20247:00 amRNSTotal Voting Rights
30th Nov 20237:03 amRNSBlock Listing Application
27th Nov 20237:00 amRNSBlock Listing Interim Review
30th Oct 20237:00 amRNSBATM receives $3m cyber security order
23rd Oct 20237:00 amRNSADOR Diagnostics secures $7.5m investment
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20233:30 pmRNSHolding(s) in Company
16th Oct 20237:00 amRNSNew Edgility order for US Emergency Services
9th Oct 20237:00 amRNSResponse to recent developments in Israel
6th Sep 20237:00 amRNSBATM receives $3.4m cyber security contract
29th Aug 20237:00 amRNSInterim Results
13th Jul 202311:30 amRNSResult of AGM and Director Appointment
8th Jun 20237:00 amRNSNotice of Annual General Meeting
6th Jun 20237:00 amRNSCapital Markets Day
5th Jun 20237:00 amRNSNew contract win for Edgility
10th May 20232:30 pmRNSCapital Markets Day and Investor Presentation
17th Apr 20237:00 amRNSEdgility rollout progressing ahead of schedule
4th Apr 20233:30 pmRNSAnnual Financial Report
6th Mar 20237:00 amRNSFull Year Results
24th Feb 20237:00 amRNSNotice of Results
1st Feb 20237:00 amRNSAppointment of Chief Financial Officer
9th Jan 20237:00 amRNSBATM receives $26m cyber security order
3rd Jan 20233:30 pmRNSGrant of Options
21st Dec 202212:00 pmRNSResult of AGM
21st Dec 20227:00 amRNSTransaction in Own Shares and TVR
20th Dec 20227:00 amRNSTransaction in Own Shares and TVR
19th Dec 20227:00 amRNSTransaction in Own Shares and TVR
16th Dec 20227:00 amRNSTransaction in Own Shares and TVR
15th Dec 20227:00 amRNSTransaction in Own Shares and TVR
14th Dec 20227:00 amRNSTransaction in Own Shares and TVR
13th Dec 20227:00 amRNSTransaction in Own Shares and TVR
9th Dec 20227:00 amRNSTransaction in Own Shares and TVR
8th Dec 20227:00 amRNSTrading Update
25th Nov 20221:00 pmRNSBlock Listing Interim Review
24th Nov 20224:00 pmRNSNotice of Annual General Meeting
27th Oct 20227:00 amRNSADOR and BIOASTER to develop STI diagnostic tests
18th Oct 20227:00 amRNSMulti-year contract with CityFibre for Edgility
6th Oct 20227:00 amRNSDirectorate Changes
24th Aug 20227:00 amRNSInterim Results
19th Jul 20227:00 amRNSAppointment of CEO of ADOR Diagnostics
11th Jul 20227:00 amRNSBATM partners with CityFibre for Edgility
16th Jun 20224:36 pmRNSPrice Monitoring Extension
26th May 20227:00 amRNSBlock Listing Interim Review

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.